SCHEMBL932584

SCHEMBL932584

CC(C)C(=N)c1cccc(Br)c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
C1S P09871 1/20 0.62
PARP1 P09874 1/20 0.47
ALDH1A1 P00352 4/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
L3MBTL1 Q9Y468 2/20 0.46
NPC1 O15118 1/20 0.44
CASP3 P42574 1/20 0.44
RAB9A P51151 1/20 0.44
SENP8 Q96LD8 1/20 0.44
SENP7 Q9BQF6 1/20 0.44
SENP6 Q9GZR1 1/20 0.44
CHRNA1 P02708 1/20 0.44
CHRNG P07510 1/20 0.44
CHRNB1 P11230 1/20 0.44
CHRNB2 P17787 1/20 0.44
SLC6A2 P23975 1/20 0.44
CHRNB4 P30926 1/20 0.44
CHRNA3 P32297 1/20 0.44
CHRNA4 P43681 1/20 0.44
SLC6A3 Q01959 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL423581 0.77 C1S (1.00) C1SPARP1SMN1; SMN2KMT2A
SCHEMBL3178752 0.77 C1S (0.63) C1SPARP1ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL29922182 0.76 CHRNA1 (0.59) C1SPARP1ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL3125040 0.76 CHRNA1 (0.59) C1SPARP1ALDH1A1SMN1; SMN2L3MBTL1
Hydrochloric Acid SCHEMBL3764471 0.75 C1S (0.96) C1SPARP1KMT2A
SCHEMBL12599378 0.73 C1S (0.59) C1SPARP1ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL28685314 0.73 PKM (0.52) C1SALDH1A1SMN1; SMN2RAB9AHTT
SCHEMBL24934194 0.72 C1S (0.63) C1SPARP1ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL28879914 0.72 C1S (0.52) C1SPARP1ALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL2221846 0.72 C1S (0.57) C1SPARP1ALDH1A1SMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed